CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Crosslinked hyaluronic acid geldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01629134
NCT01629134N/ACompleted

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Allergan Medical·observational·Posted Jun 27, 2012·Updated Oct 13, 2014

In Brief

An observational study evaluating Crosslinked hyaluronic acid gel for Lip Augmentation. Completed, enrolled 62 participants across 1 site.

Detailed Summary

A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine in the lips.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 27, 2012
Enrollment StartJun 1, 2012
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.0 years ago

Interventions

Crosslinked hyaluronic acid geldevice

All treatments are carried out according to the physician's experience and the Directions for Use